Let’s make a difference together
Everyone at Mycovia embodies our core values of respect, integrity, perseverance, innovation, quality, and excellence every day. We seek like-minded partners to help us transform healthcare and make a meaningful difference in patients’ lives.
licensing partnerships
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Mycovia is partnered with Jiangsu Hengrui Pharmaceuticals Co., Ltd (“Hengrui”) in an exclusive agreement to develop and commercialize oteseconazole in China, including mainland China, Hong Kong, Macau, and Taiwan. In June 2023, VIVJOA® (Oteseconazole Capsules, 150 mg) received approval in China from the National Medical Products Administration and is indicated for the treatment of severe VVC, further fulfilling the unmet medical needs of women across the globe.
Read more about this partnership here
Join the journey
We’re proud to be making a difference for patients with unmet needs and are eager to partner with others who share this same drive.
